توقعات سوق تشخيص سرطان الدماغ في أوروبا حتى عام 2028 - تأثير كوفيد-19 والتحليل الإقليمي حسب نوع التشخيص (اختبار التصوير، البزل القطني، الخزعة، الاختبار الجزيئي، وغيرها)؛ نوع السرطان (الورم العصبي الصوتي، والورم النجمي، والأورام القحفية البلعومية، والأورام العصبية العقدية، والورم الأرومي الدبقي متعدد الأشكال، والأورام السحائية، والأورام البطانية العصبية، وغيرها)؛ المستخدم النهائي (المستشفيات والعيادات المتخصصة والمراكز الجراحية المتنقلة وغيرها)

1.           Introduction

1.1          Scope of the Study

1.2          The Insight Partners Research Report Guidance

1.3          Market Segmentation

1.3.1          Brain Cancer Diagnostics Market – By Diagnostic Type

1.3.2          Brain Cancer Diagnostics Market – By Cancer Type

1.3.3          Brain Cancer Diagnostics Market – By End User

1.3.4          Europe Brain Cancer Diagnostics Market – By Country

2.           Europe Brain Cancer Diagnostics Market – Key Takeaways

3.           Research Methodology

3.1          Coverage

3.2          Secondary Research

3.3          Primary Research

4.           Europe Brain Cancer Diagnostics Market – Market Landscape

4.1          Overview

4.2          PEST Analysis

4.2.1          Brain Cancer Diagnostics Market- Europe PEST Analysis

4.3          Expert Opinion

5.           Europe Brain Cancer Diagnostics Market - Key Market Dynamics

5.1          Market Drivers

5.1.1          Increase in Prevalence of Brain Cancer

5.1.2          Rise in Number of Cigarette Smokers

5.2          Market Restraints

5.2.1          High Cost of Diagnosis

5.3          Future Trends

5.3.1          Use of Stimulated Raman Histology (SRH)?Artificial Intelligence (AI) to Enhance Brain Tumor Diagnosis During Surgery

5.4          Impact Analysis

6.           Brain Cancer Diagnostics Market – Europe Analysis

6.1          Europe Brain Cancer Diagnostics Market Revenue Forecasts and Analysis

7.           Europe Brain Cancer Diagnostics Market Analysis and Forecasts To 2028 – By Diagnostic Type

7.1          Overview

7.2          Brain Cancer Diagnostics Market Revenue Share, by Diagnostic Type (2020 and 2028)

7.3          Imaging Tests

7.3.1          Overview

7.3.2          Imaging Tests: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.3          MRI

7.3.3.1             Overview

7.3.3.2             MRI: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.4          CT Scan

7.3.4.1             Overview

7.3.4.2             CT Scan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.5          Positron emission tomography (PET)

7.3.5.1             Overview

7.3.5.2             Positron emission tomography (PET): Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4          Lumbar Puncture

7.4.1          Overview

7.4.2          Lumbar Puncture: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.5          Biopsy

7.5.1          Overview

7.5.2          Biopsy: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.6          Molecular Testing

7.6.1          Overview

7.6.2          Molecular Testing: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.7          Others

7.7.1          Overview

7.7.2          Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.           Europe Brain Cancer Diagnostics Market Analysis and Forecasts To 2028 – By Cancer Type

8.1          Overview

8.2          Brain Cancer Diagnostics Market Revenue Share, by Cancer Type (2020 and 2028)

8.3          Astrocytomas

8.3.1          Overview

8.3.2          Astrocytomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.4          Glioblastoma Multiforme

8.4.1          Overview

8.4.2          Glioblastoma Multiforme: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.5          Ependymomas

8.5.1          Overview

8.5.2          Ependymomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.6          Others

8.6.1          Overview

8.6.2          Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.           Brain Cancer Diagnostics Market Analysis – By End user

9.1          Overview

9.2          Brain Cancer Diagnostics Market Revenue Share, by End User (2020 and 2028)

9.3          Hospitals

9.3.1          Overview

9.3.2          Hospitals: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.4          Specialty Clinics

9.4.1          Overview

9.4.2          Specialty Clinics: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.5          Ambulatory Surgical Centers

9.5.1          Overview

9.5.2          Ambulatory Surgical Centers: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.6          Others

9.6.1          Overview

9.6.2          Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.        Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 – Geographical Analysis

10.1        Europe: Brain Cancer Diagnostics Market Revenue and Forecasts to 2028

10.1.1        Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Country (%)

10.1.2        UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.1          UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.2          UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

10.1.2.2.1           UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

10.1.2.3          UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

10.1.2.4          UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.1.3        Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.3.1          Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.3.2          Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

10.1.3.2.1           Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

10.1.3.3          Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

10.1.3.4          Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.1.4        France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.4.1          France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.4.2          France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

10.1.4.2.1           France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

10.1.4.3          France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

10.1.4.4          France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.1.5        Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.5.1          Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.5.2          Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

10.1.5.2.1           Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

10.1.5.3          Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

10.1.5.4          Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.1.6        Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.6.1          Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.6.2          Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

10.1.6.2.1           Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

10.1.6.3          Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

10.1.6.4          Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.1.7        Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.7.1          Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.7.2          Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

10.1.7.2.1           Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

10.1.7.3          Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

10.1.7.4          Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

11.        Impact Of COVID-19 Pandemic on Europe Brain Cancer Diagnostics Market

11.1        Europe: Impact Assessment of COVID-19 Pandemic

12.        Industry Landscape

12.1        Overview

12.2        Growth Strategies Done by the Companies in the Market, (%)

12.1        Organic Developments

12.1.1        Overview

12.2        Inorganic Developments

12.2.1        Overview

13.        Company Profiles

13.1        THERMO FISHER SCIENTIFIC INC.

13.1.1        Key Facts

13.1.2        Business Description

13.1.3        Products and Services

13.1.4        Financial Overview

13.1.5        SWOT Analysis

13.1.6        Key Developments

13.2        Siemens Healthineers AG

13.2.1        Key Facts

13.2.2        Business Description

13.2.3        Products and Services

13.2.4        Financial Overview

13.2.5        SWOT Analysis

13.2.6        Key Developments

13.3        GE Healthcare

13.3.1        Key Facts

13.3.2        Business Description

13.3.3        Products and Services

13.3.4        Financial Overview

13.3.5        SWOT Analysis

13.3.6        Key Developments

13.4        Biocept, Inc.

13.4.1        Key Facts

13.4.2        Business Description

13.4.3        Products and Services

13.4.4        Financial Overview

13.4.5        SWOT Analysis

13.4.6        Key Developments

13.5        Koninklijke Philips N.V.

13.5.1        Key Facts

13.5.2        Business Description

13.5.3        Products and Services

13.5.4        Financial Overview

13.5.5        SWOT Analysis

13.5.6        Key Developments

13.6        Canon Medical Systems

13.6.1        Key Facts

13.6.2        Business Description

13.6.3        Products and Services

13.6.4        Financial Overview

13.6.5        SWOT Analysis

13.6.6        Key Developments

13.7        Hitachi, Ltd.

13.7.1        Key Facts

13.7.2        Business Description

13.7.3        Products and Services

13.7.4        Financial Overview

13.7.5        SWOT Analysis

13.7.6        Key Developments

13.8        Neusoft Medical Systems

13.8.1        Key Facts

13.8.2        Business Description

13.8.3        Products and Services

13.8.4        Financial Overview

13.8.5        SWOT Analysis

13.8.6        Key Developments

14.        Appendix

14.1        About the Insight Partners

14.2        Glossary of Terms

Table 1.              UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type US$ Mn)

Table 2.              UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test US$ Mn)

Table 3.              UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type US$ Mn)

Table 4.              UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User US$ Mn)

Table 5.              Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

Table 6.              Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

Table 7.              Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type US$ Mn)

Table 8.              Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User US$ Mn)

Table 9.              France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

Table 10.            France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

Table 11.            France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

Table 12.            France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

Table 13.            Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

Table 14.            Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

Table 15.            Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

Table 16.            Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

Table 17.            Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

Table 18.            Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

Table 19.            Spain Brain Cancer Diagnostics Market Revenue and Forecast to 2028, by Cancer Type (USD Million)

Table 20.            Spain Brain Cancer Diagnostics Market Revenue and Forecast to 2028, by End User (USD Million)

Table 21.            Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

Table 22.            Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

Table 23.            Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

Table 24.            Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

Table 25.            Organic Developments in the Brain Cancer Diagnostics Market

Table 26.            Inorganic Developments in the Brain Cancer Diagnostics Market

Table 27.            Glossary of Terms, Brain Cancer Diagnostics Market

Figure 1.            Brain Cancer Diagnostics Market Segmentation

Figure 2.            Europe Brain Cancer Diagnostics Market Overview

Figure 3.            Imaging Test Segment Held Largest Share of Diagnostic Type in Brain Cancer Diagnostics Market

Figure 4.            Germany is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.            Brain Cancer Diagnostics Market - Europe PEST Analysis

Figure 6.            Brain Cancer Diagnostics Market Impact Analysis of Driver and Restraints

Figure 7.            Europe Brain cancer diagnostics Market – Revenue Forecasts and Analysis – 2020- 2028

Figure 8.            Brain Cancer Diagnostics Market Revenue Share, by Diagnostic Type (2020 and 2028)

Figure 9.            Imaging Tests: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 10.          MRI: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11.          CT Scan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.          Positron emission tomography (PET): Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.          Lumbar Puncture: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.          Biopsy: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.          Molecular Testing: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.          Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.          Brain Cancer Diagnostics Market Revenue Share, by Cancer Type (2020 and 2028)

Figure 18.          Astrocytomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.          Glioblastoma Multiforme: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.          Ependymomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.          Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.          Brain Cancer Diagnostics Market Revenue Share, by End User (2020 and 2028)

Figure 23.          Hospitals: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.          Specialty Clinics: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.          Ambulatory Surgical Centers: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.          Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.          Europe: Brain Cancer Diagnostics Market Revenue Overview, by Country, 2021 (US$ MN)

Figure 28.          Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Country (%)

Figure 29.          UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 30.          Germany Brain Cancer Diagnostics Products Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 31.          France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 32.          Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 33.          Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 34.          Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 35.          Impact of COVID-19 Pandemic in European Country Markets

1. Thermo Fisher Scientific Inc.
2. Siemens Healthineers A
3. GE Healthcare
4. Biocept, Inc.
5. Koninklijke Philips N.V
6. Canon Medical Systems
7. Hitachi, Ltd.
8. Neusoft Medical Systems

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe brain cancer diagnostics market.
• Highlights key business priorities in order to assist companies to realign their business strategies
• The key findings and recommendations highlight crucial progressive industry trends in the Europe brain cancer diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
• Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the brain cancer diagnostics market, as well as those hindering it
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution